Ceramides and Type 2 Diabetes: A Scoping Review of Mechanisms, Insulin Resistance, and Nutritional Interventions

This scoping literature review examined the relationship between ceramides and type 2 diabetes mellitus (T2DM), as well as nutrition interventions that are shown to lower circulating ceramides. Ceramides, bioactive sphingolipids implicated in lipid dysregulation, play a critical role in the development of insulin resistance in obesity-related T2DM. Since diet strongly influences ceramide synthesis, targeted nutritional interventions represent a promising strategy to counteract their impact and improve metabolic health. A systematic search following Preferred Reporting Items for Systematic Reviews and Meta-Analyses Scoping Review (PRISMA-ScR) guidelines was conducted across PubMed, Gale Health and Medicine, Google Scholar, and EBSCO for English language articles published between 2000 and 2025. From the initial 70 records, 45 studies were selected using our systematic, rigorous selection criteria. Evidence demonstrated that high-fat diets, in particular saturated fats, elevate plasma ceramide levels, which are strongly associated with insulin resistance and T2DM. Nutrition interventions shown to lower ceramides include limiting saturated fats to less than 6% of total calories, increasing dietary fiber to ≥35 g/day, and following the Diabetes Plate guidelines. Collectively, the evidence supports a mechanistic and associative link between ceramides and T2DM. It highlights the emerging potential of plasma ceramides as biomarkers for insulin resistance and disease risk. Continuing research into nutrition‑based ceramide modulations may inform future diabetes prevention and management strategies.